Monday, September 26, 2022
wellness India Expo
Home Tags Cancer

Tag: Cancer

University East Anglia breakthrough reveals how prostate cancer may begin

The team hope their work could help scientists better understand the causes of prostate cancer, and even prevent it altogether

Niramai expands its presence, launches screening facility in Kerala

Niramai’s innovative solution called ‘Thermalytix’, is an automated breast health screening and diagnostic tool, which combines thermal imaging with artificial intelligence

Nanomedicine for liver cancer developed by Amrita researchers gets US, Australia...

The medicine, that gets triggered by external radio waves, can be used not only for medical imaging of tumors but also for targeted drug delivery

Study identifies gene that could help fight lethal infection Candidiasis

Named CSA6, the gene has been identified in Candida albicans, a fungus notorious for causing high morbidity and mortality rates under certain immuno-compromised conditions

MGM Healthcare launches dedicated Cancer Centre in Chennai

The state-of-the-art facility is said to be designed to be a holistic destination for cancer treatment

IIT Guwahati to set up Centre for Advanced Research on Diagnostics...

Institute signed an MoU with Karkinos Healthcare to establish a Centre of Advanced Research on Diagnostics in Cancer (C-CARD), a first of its kind in the nation with an IIT

Scientific community celebrates India’s first indigenous vaccine for cervical cancer

A formal announcement of this vaccine will be made by the Minister of State (IC) for Science and Technology, Dr Jitendra Singh in New Delhi today

Newly identified gene could be clue to treatment of fungal infection...

The gene called CSA6 has been identified in Candida albicans a fungal species infamous for causing high rates of morbidity and mortality under certain immuno-compromised conditions such as AIDS or during cancer treatment

Apollo Proton Cancer Centre in India becomes Asia’s first & exclusive...

In association with Ion Beam Applications (IBA), Belgium, Apollo Proton Cancer Centre will impart knowledge through its advanced training and education program on proton therapy to clinicians.

DCGI approves AstraZeneca’s Lynparza as a monotherapy for high-risk early breast...

Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer